Our new work is now available online: science.org/doi/10.1126/sc… #immunotherapy #microbiome #dietaryfiber #probiotics

⚡Our April issue is live! ⚡ 🧵1/4 In this Focus issue dedicated to The Future of Cancer Research, we take stock of progress and explore ways to deliver research and care that is innovative, sustainable, and patient-focused. Cancer at Nature Portfolio 🦀 nature.com/nm/volumes/28/…

Happening today at noon! To watch Dr. John Stagg's seminar, please send email to [email protected] for all the details. #CancerResearch Madhuri Koti Centre de recherche du CHUM

Canadian Cancer Stats 2022 has been released by Canadian Cancer Society Statistics Canada Health Canada and PHAC The published paper can seen here cmaj.ca/content/194/17… showing progress in declining rates but our aging population continues to have a big impact #cancerstats #SolvingCancerTogether

#CCTG recognizes #Immune2Cancer Day and our partnership with Cancer Research Institute - working together to conduct the clinical research that proves emerging #immunotherapy strategies are effective.

Review: iRECIST and atypical patterns of response to immuno-oncology drugs bit.ly/3ox42lf #JITC Pierre-Olivier Gaudreau MD PhD 3/4

jitc.bmj.com/content/10/3/e…

Deeply saddened by news of Jill Hamer-Wilson’s passing. As a Patient Partner, Jill devoted her time and experience to clinical trial advocacy and transforming patient engagement in research. This week’s 3CTN Annual Stakeholder Meeting will be dedicated to her memory and legacy.

Check out the Journal for ImmunoTherapy of Cancer Special Series on Liquid Biopsies! sitcancer.org/research/jitc-… jitc.bmj.com/content/11/1/e… jitc.bmj.com/content/11/1/e… jitc.bmj.com/content/10/12/… jitc.bmj.com/content/11/1/e… jitc.bmj.com/content/11/1/e… Mark Friends of Cancer Research Society for Immunotherapy of Cancer Johns Hopkins Kimmel Cancer Center

Very promising work from our colleagues at McGill, using AI to predict early-stage NSCLC recurrence following surgery. Congratulations to the whole team! @sori_mark logan Daniela Quail Lab @DoctorJspicer Joubert, Philippe Miranda Yu nature.com/articles/s4158…

Dr. Jarushka Naidoo discusses resistance to immunotherapy- important to have consistent terminology. Highlights importance of the gut microbiota and emerging circulating markers of resistance. #ILCDebates2023

#CCTG is looking for a Patient Representative Volunteer to support the Lung Disease Site Committee & represent the perspective of patients & their families, & the public at large, in the development & delivery of clinical trials. #SolvingCancerTogether ctg.queensu.ca/bulletin/cctg-…

Happy #WomenInScience Day! Let us get rid of stereotypes, challenge gender bias and beat discrimination that hold women & girls back in science, technology, engineering and maths! on.unesco.org/WomenInScience

Libérer le potentiel des femmes = libérer le potentiel de l’humanité ! ✨ En cette #JournéeDesFemmes, réclamons un monde digital inclusif. Le changement technologique et l’éducation à l’ère du numérique doivent nous aider à réaliser l'#ÉgalitéDesGenres. on.unesco.org/2EGAx9l

(1/3) Excited to share our work on genomic and transcriptomic predictors of response to PD-(L)1 inhibitors in NSCLC Nature Genetics; nearly 400 pts and growing, forming the SU2C/Mark Foundation cohort nature.com/articles/s4158…

Pleased to announce our June seminar speaker! Dr. Caroline Lamarche lamarche caroline will be presenting via Zoom on June 5th at noon. Hosted by Pierre-Olivier Gaudreau MD PhD For Zoom details, please email [email protected]

(1/3) Going to ASCO this week? Join us for Dr. Quincy Chu's oral presentation highlighting the phase 3 results of the IND.227 trial in mesothelioma: Time: Jun/3/2023, 3:00 PM-6:00 PM CDT Hall B1 meetings.asco.org/abstracts-pres… IND Program CCTG CCTG #mesothelioma

(2/3) I also invite you to visit our CCTG IND trial posters at ASCO, including IND.240 (Dr. Helen MacKay): Time: Jun/5/2023, 1:15 PM CDT Hall A meetings.asco.org/abstracts-pres… IND Program CCTG CCTG #immunotherapy #ovariancancer

(3/3) As well as the CCTG IND trial poster for the IND.238 trial (Dr. Peter Ellis & Dr. Sara Taylor): Time: Jun/3/2023, 8:00 AM-11:00 AM CDT Hall A meetings.asco.org/abstracts-pres… IND Program CCTG CCTG #immunotherapy #rechallenge #immunerelatedadverseevent

Dr. Joseph Pater #CCTG's founding director recognized for a lifetime of work in cancer research with his appointment as an Officer of the Order of Canada - his clinical research has improved the lives of Canadians with cancer. #OrderOfCanada #GGHonours  ctg.queensu.ca/cctg_news/foun…